glaucoma
Marijuana Like Compound in Brain Shows Fragile X Syndrome May Be Treatable
The federal government has shown an unwillingness to entertain operational changes. In particular, federal authorities still prefer to suppress the monumental potential of medical marijuana as it is an uncomfortable topic because it may require regulation, rescheduling, and the admission of an almost 100 year mistake.
Medical marijuana breakthroughs are occurring at a frequent rate. Last week alone, marijuana.net reported on a breakthrough that showed cannabis had the potential to fight epilepsy. Perhaps even more groundbreaking was a study that showed components of marijuana had the ability to slow the spreading of cancer cells. Of course this builds on years research that have shown marijuana to be a miracle of sorts, and has demonstrated promise in fighting chronic pain, muscle conditions, MS, complications related to chemotherapy, glaucoma, the spreading of HIV/AIDS, nausea, PTSD etc (it would take too much time to list them all).
Fragile X Syndrome now joins the constantly growing list of medical conditions that may benefit from marijuana research. This complex condition is associated with autism and mental retardation in men and considered the most common cause of both. Fragile X syndrome is a mutation of the FMR1 gene in the X chromosome that is passed on by the mother. This mutation can result in mental disability, hyperactivity, physical disability, and language deficiencies.
The main problem has to do with messages and receptors in the brain. Researchers have now found that 2-AG, a marijuana like compound and endocannabinoid transmitter is showing considerable promise in reducing fragile x syndrome symptoms. Daniele Piomelli, a professor at UC Irvine was the lead researcher of the study and recently said “This compound is so important in regulating neural transmission in the brain that it seemed possible that it might be involved in a disease that is so devastating on brain function.” When the 2-AG signal is boosted, it appears the brain will relay the correct messages, at least in lab mice. Proffessor Piomelli explained “We asked, ‘If we boost a little bit of that 2-AG signal, will it be enough to correct the problems that occur in fragile X mice? The answer was a resounding, Yes. We corrected the physiology, but most importantly, we corrected their behavior. The animals behaved just like normal animals. They didn’t have the fears and movement problems of those with fragile X.”
We are only now seeing the tip of the iceberg as decades of potential research have been lost due to senseless marijuana regulations. However, as groundbreaking discoveries that have eluded modern medicine for decades are coming through marijuana research, how long can we truly afford to look the other way. As politicians are desperate not to admit mistakes (see Mitt Romney Campaign), there is something admirable about those who stand up, admit fault, and reverse a century long problem.
New Jersey Shows that the Wheels of Progression Cannot Be Stopped
Despite the best efforts of Governor Chris Christie, state legislators, and local townships, New Jersey’s medical marijuana program is moving along. Patients have clearly stated that they are in favor of the program that was passed several years ago only to see bureaucratic delays on every level. However as marijuana becomes widely accepted and research confirms its medical usefulness and lack of side effects, those trying to slow the unstoppable force of progression seem to be accepting the futility of such action.
Other states have deployed similar political tactics to delay the start of their marijuana program. Arizona’s governor Jan Brewer has tried several times to prevent dispensaries from serving patients. The result has created a rift between voters and the governor. Looking to avoid such tension New Jersey has given approval for patients to register and receive their medical marijuana identification cards. Patients with terminal cancer, Crohn’s disease, glaucoma, MS, and other qualifying conditions will have the opportunity to apply for the ID card. Patients can go to the New Jersey Department of Health Website to register or call 609-292-0424. A registration card costs $200 and will be valid for 2 years.
Patients in New Jersey may still have to wait a bit for their medication as only 6 dispensaries have been approved and only one seems close to opening its doors. Greenleaf Compassion Center has previously stated that it would have a crop available to distribute by September. However they still have not yet received the final approval to dispense marijuana. While there still may be time before the program is serving patients around the state, it seems to finally be moving on the right track. There are over 150 doctors have registered to be a part of the program. State Assemblyman Assemblyman Reed Gusciora also felt the program was moving in the right direction and recently said “The opening of a patient registry is a crucial and welcome step. . . . This represents the light at the end of the tunnel.”
Our elected officials often forget they are expected to work for the people. New Jersey officials have finally gotten the message but were close to facing lawsuits. Democracy is all about abiding by the will of the people and right now the people are expecting progress. Trying to stop that is as pointless as trying to stop the ocean currents.
CBD in Marijuana found to Treat Schizophrenia with few Side Effects
Within a matter of weeks the United States Supreme Court will issue a ruling on the controversial “Obamacare” program. In particular, the mandate that requires Americans to carry health insurance has drawn the most scrutiny and is being challenged on its constitutionality. Combining that with Mitt Romney’s campaign going national after winning the GOP nomination, the healthcare reform battle should be front and center as both Romney and Obama (often considered very similar plans) have enacted sweeping health care changes.
Luckily in the meantime we have less partisan political healthcare updates to lift our spirits. This week researchers at The University of Cologne in Germany have found that CBD (a cannabinoid found in marijuana) looks to have excellent potential in treating schizophrenia symptoms. Of the 39 patients who participated in the study, 20 were treated with CBD while the others were treated with amisulpride, a drug not legal in the U.S. but similar to medications used in America. Daniel Piomelli, co-author of the study was pleased with the results and said “The results were amazing. Not only was CBD as effective as standard antipsychotics, but it was also essentially free of the typical side effects seen with antipsychotic drugs.”
This development builds on many of the recent studies that have linked health and quality of life to marijuana. Soldiers have often reported that marijuana use has helped with their PTSD symptoms. Recently, marijuana.net reported on a study that showed cannabis relieved patient’s painful MS symptoms. Additionally, marijuana has been linked to help patients suffering from cancer, AIDS, Glaucoma, chronic pain, muscular dystrophy, migraines, and of course so many other ailments. We encourage readers in our comment section to share stories about these or other medical issues marijuana aids.
Schizophrenia has baffled medical professionals for centuries and perhaps even thousands of years. Egyptians have described ancient ailments over two thousand years ago that sound very much like what we call schizophrenia today. Treatments in the middle ages included exorcisms and even drilling holes in the head in order to draw out the “evil spirits”. In the modern times scientists came up with a new method that was not much more sophisticated. The lobotomy may indeed treat schizophrenia, with a major side effect being that the patient is turned into a zombie. Let us not forget that shock therapy which is still used today even as scientists have not been able to fully determine why it produces results, or often does not. These extreme treatments only highlight just how incredible the German discovery is for patients suffering from this long misunderstood condition.
The hope is that research such as this will also be conducted in the United States. Healthcare is still a prevailing issue in the United States with our country seeming like they are reserved to second class care. The president’s plan has increased coverage but is not as far reaching as initially thought on the campaign trail. This may not be his fault entirely as the GOP and economy presented major roadblocks. Either way, this marijuana research is encouraging and could provide patients with relief immediately with far less economic cost than the typical big pharmaceutical treatments. As the complexity of the health care arguments plays itself out in the media, let us keep in mind that there is one simple source for so much healing.